bladder cancer Clinical Trials and Research
Also known as: bladder carcinoma, urothelial carcinoma, transitional cell carcinoma, tcc, urinary bladder cancer · ICD-10: C67
Bladder cancer occurs when cells in the bladder grow uncontrollably, often starting in the lining. Clinical trial research focuses on developing new therapies, improving early detection methods, and preventing recurrence. Find a Trial helps patients search for active studies investigating this condition.
Search bladder cancer trials →
Common questions about bladder cancer clinical trials
What are the different phases of bladder cancer clinical trials?
Clinical trials typically progress through phases 1, 2, and 3. Phase 1 studies assess safety, Phase 2 evaluates effectiveness and side effects, and Phase 3 compares new treatments to existing ones, according to information from ClinicalTrials.gov.
Do clinical trials for bladder cancer cost money?
Generally, study-related medical care, tests, and drugs are provided at no cost to participants. However, standard medical care not related to the trial and travel expenses may not be covered, as detailed in study protocols on ClinicalTrials.gov.
What new treatments are being studied for bladder cancer?
Current research, as shown on ClinicalTrials.gov and NIH RePORTER, explores immunotherapies, targeted therapies, and novel chemotherapy combinations. Scientists are also investigating gene therapies and new surgical techniques to improve outcomes for patients.
What types of interventions are common in bladder cancer trials?
Interventions often include new drug formulations, different radiation therapy approaches, or novel surgical techniques. Some trials also focus on lifestyle changes or supportive care to improve quality of life, according to ClinicalTrials.gov.
Are there specific biomarkers important in bladder cancer clinical trials?
Yes, researchers are investigating biomarkers like FGFR alterations, PD-L1 expression, and specific genetic mutations. These markers can help identify patients who might respond best to certain targeted therapies or immunotherapies, as explored in studies on NIH RePORTER.
What might prevent someone from joining a bladder cancer trial?
Common exclusion criteria can include certain pre-existing medical conditions, specific prior treatments, or other active cancers. These criteria help ensure the safety of participants and the integrity of study results, as outlined on ClinicalTrials.gov.
What research is being done on preventing bladder cancer recurrence?
Research focuses on intravesical therapies, such as BCG or new drug instillations, after initial treatment. Studies also investigate surveillance strategies and lifestyle interventions to reduce the risk of the cancer returning, according to data from ClinicalTrials.gov.
How to find a bladder cancer trial that fits you
- Describe your bladder cancer situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all bladder cancer trials →